Platinum Investment Management’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-846
Closed -$292K 122
2025
Q1
$292K Buy
846
+554
+190% +$178K 0.02% 93
2024
Q4
$87.6K Buy
+292
New +$102K 0.01% 96
2023
Q1
Sell
-401
Closed -$96.2K 151
2022
Q4
$96.2K Hold
401
﹤0.01% 114
2022
Q3
$74K Sell
401
-96
-19% -$19.1K ﹤0.01% 118
2022
Q2
$84K Buy
497
+170
+52% +$36.5K ﹤0.01% 118
2022
Q1
$82K Sell
327
-35
-10% -$8.79K ﹤0.01% 128
2021
Q4
$93K Hold
362
﹤0.01% 129
2021
Q3
$88K Sell
362
-128
-26% -$31.3K ﹤0.01% 133
2021
Q2
$101K Hold
490
﹤0.01% 133
2021
Q1
$92K Hold
490
﹤0.01% 131
2020
Q4
$81K Sell
490
-54
-10% -$7.9K ﹤0.01% 141
2020
Q3
$68K Buy
+544
New +$67.3K ﹤0.01% 139

Other funds holding HCA

Platinum Investment Management's HCA Position: Q2 2025 in Review

Platinum Investment Management sold out of HCA Healthcare (HCA) in Q2 2025, closing a stake of 846 shares — an estimated $292K sold.

Platinum Investment Management first reported a position in HCA in Q3 2020 and held it in 12 quarters. The position peaked at $292K in Q1 2025. 1,248 funds tracked by Wall St. Rank hold HCA as of Q2 2025.

  • Platinum Investment Management reported no remaining HCA Healthcare position as of Q2 2025 after selling out during the quarter.
  • Platinum Investment Management sold 846 HCA Healthcare shares in Q2 2025, an estimated $292K.
  • Platinum Investment Management first reported a position in HCA Healthcare in Q3 2020 and held it in 12 quarters.
  • Platinum Investment Management's HCA Healthcare position peaked at $292K in Q1 2025.
  • 1,248 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2025.

Based on Platinum Investment Management's 13F filing for Q2 2025, filed 21 Jul 2025.